TMS Research Committee Activities

Mar 21, 2019

Below is a description of updates and progress on projects related to The Mastocytosis Society (TMS) Research Committee. Major activities and initiatives are noted, but for a full list of activities in which the committee is involved, please see our Join the Research Committee section of this website. Where applicable, click on titles for more information.


2019 American Academy of Allergy Asthma and Immunology (AAAAI) Annual Meeting

Members of the Research Committee joined others from the TMS team at the 2019 AAAAI conference in San Francisco, CA in February. They attended a variety of medical and scientific presentations, the AAAAI Mast Cell Disorders Committee and Lay Organization meetings, hosted a planning meeting to help prepare for the American Initiative in Mast Cell Diseases (AIM) Inaugural Physician/Investigator Meeting (to be held in May 2019 in the San Francisco Bay Area), participated in other meetings related to various TMS initiatives and presented a poster on data from the 2018 TMS MCAS Patient Survey.


2018 American Society of Hematology (ASH) Annual Meeting

Dr. Jennings joined other members of the TMS team at the December 2018 ASH Annual Meeting in San Diego, CA, where TMS had a booth, attended medical/scientific sessions and participated in several meetings related to various TMS initiatives.


American Initiative in Mast Cell Diseases (AIM)

Many of us at TMS have been working closely with leaders of the American Initiative in Mast Cell Diseases (AIM), co-chaired by Jason Gotlib, MD, MS, and Cem Akin, MD, PhD, on the AIM Inaugural Physician/Investigator Conference, which is planned for May 2019 in the San Francisco Bay Area. AIM is intended to become a network of mast cell disease centers in the Americas. Plans to establish AIM grew out of a series of Mast Cell Disorder Challenges Meetings that TMS hosted during past ASH and AAAAI Annual Meetings (and prior to several European Competence Network in Mastocytosis Annual Meetings).


TMS Support of Mast Cell Disorder Research Surveys and Drug Development Companies

TMS works with researchers to make our mast cell disease community aware of patient surveys that are related to our disease set, including those developed and conducted by TMS. Our latest survey initiative was the 2018 TMS Mast Cell Activation Syndrome Patient Survey.

In addition, we work with drug development companies to help them connect with our patient population, for those patients who might be interested in becoming involved in the drug development process.  Our community can provide valuable information to these companies, by sharing our experiences and allowing industry representatives to better understand what patients in our community have to deal with on a daily basis.


TMS Article in Mastocytosis issue of Immunology and Allergy Clinics of North America

TMS published a collaborative article, “Patient Perceptions in Mast Cell Disorders”, in the Mastocytosis issue of Immunology and Allergy Clinics of North America. Inclusion of an article by TMS authors in this special issue, partnering with others in the field of mast cell diseases, is an exciting first for TMS!


2010 TMS Patient Survey Update

The second set of results of the TMS 2010 online survey of patients with mast cell disorders, Patient Clinical Experiences and Beyond, have now been published!* Please click on the link above for more information and links to all reports on this survey.


ICD-10-CM Codes for Mast Cell Activation Syndromes (MCAS) and Mastocytosis

In 2013-14, TMS Research Committee members worked with the Mast Cell Disorders Committee of the AAAAI (including Drs. Arnold Kirshenbaum, Joseph Butterfield, Cem Akin, Mariana Castells and Catherine Weiler) to create proposals for new medical diagnostic (ICD-10-CM) codes for MCAS and revised codes for mastocytosis.  These proposals were submitted jointly by TMS and the AAAAI to the Centers for Disease Control and Prevention (CDC) and were presented during the CDC Coordination and Maintenance Committee Meetings held March 19-20, 2014 (MCAS) and September 23-24, 2014 (mastocytosis).  ICD-10-CM codes related to MCAS became effective in October 2016 and updates to ICD-10-CM codes for mastocytosis were implemented in October 2017.


Additional Research Activities

  • Our committee collaborates with other TMS committees and our Medical Advisory Board on the creation of updated educational materials for TMS.

*First set of survey results has been previously published:

  1. Jennings S, Russell N, Jennings B, Slee V, Sterling L, Castells M, et al. The Mastocytosis Society Survey on Mast Cell Disorders: Patient Experiences and Perceptions. J Allergy Clin Immunol Pract. 2014;2(1):70-6.
  2. TMS Chronicles (Winter 2014)

March 2019